European Vaccine Research and Development Infrastructure (TRANSAVC2) launches call to access training.
TRANSVAC2 offers technical and theoretical training at leading European centres on Vaccine R&D. The following modules are open for applications:
M1 Clinical vaccine development and biomanufacturing, 22-25 September 2020 at University of Oxford, Oxford, UK
M2 Human and Veterinary Vaccinology, 26-30 October 2020 at University of Oxford, Oxford, UK
Applications should be submitted by July 15th, 2020 at www.transvac.org
TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.
